Lexology November 19, 2020
Epstein Becker Green

On November 12, 2020, the Trump administration published its final rule on price transparency (the “Final Rule”) requiring affected entities to publicly release personalized information on out-of-pocket costs as well as certain negotiated rates, stating that transparency in health coverage requirements will improve competition and “strengthen America’s health care system by giving health care consumers, researchers, regulators, lawmakers, health innovators, and other health care stakeholders the information they need to make, or assist others in making informed decisions about health care purchases.”[1] Entities affected include most group health plans, including employer group health plans, and health insurance companies offering group and individual health coverage (“plans and issuers”). Additionally, the Final Rule makes certain changes to medical loss ratio (“MLR”) calculations,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Health System / Hospital, Healthcare System, Insurance, Patient / Consumer, Pricing / Spending, Provider
How Hospitals Can Avoid a Price Transparency Audit: Part III
Federal Legislation And State Policy Efforts Promote Access To And Use of Discounted Cash Prices
Zelis Debuts In-Network Pricing Tool for Health Plans
Hospitals coming into compliance after price transparency fines
Cross-country comparison in health care price growth: 2000-2020

Share This Article